Grufity logoGrufity logo

Humana Inc Stock Research

HUM

488.36USD+3.50(+0.72%)Market Closed

Market Summary

USD488.36+3.50
Market Closed
0.72%

HUM Alerts

HUM Stock Price

HUM RSI Chart

HUM Valuation

Market Cap

61.8B

Price/Earnings (Trailing)

22.03

Price/Sales (Trailing)

0.67

EV/EBITDA

12.03

Price/Free Cashflow

17.83

HUM Price/Sales (Trailing)

HUM Profitability

EBT Margin

3.84%

Return on Equity

18.33%

Return on Assets

6.52%

Free Cashflow Yield

5.61%

HUM Fundamentals

HUM Revenue

Revenue (TTM)

92.9B

Revenue Y/Y

6.58%

Revenue Q/Q

-1.58%

HUM Earnings

Earnings (TTM)

2.8B

Earnings Y/Y

-7.14%

Earnings Q/Q

-101.26%

Price Action

52 Week Range

410.17571.30
(Low)(High)

Last 7 days

-2.5%

Last 30 days

-4.1%

Last 90 days

-5.3%

Trailing 12 Months

11.1%

HUM Financial Health

Current Ratio

1.52

HUM Investor Care

Dividend Yield

0.54%

Dividend/Share (TTM)

2.73

Buy Backs (1Y)

1.50%

Diluted EPS (TTM)

22.08

Peers (Alternatives to Humana)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
439.0B
324.2B
-3.12% -7.42%
21.82
1.35
12.71% 16.40%
91.1B
180.5B
-13.92% 6.07%
13.64
1.92
3.70% 24.58%
61.8B
92.9B
-4.10% 11.05%
22.03
0.67
11.81% -4.33%
35.3B
144.5B
-9.19% -25.06%
29.38
0.24
14.74% -10.76%
MID-CAP
5.2B
2.3B
3.17% 35.63%
86.23
2.28
2.85% -58.05%
4.9B
831.2M
-10.57% -12.87%
-83.44
5.9
12.11% -862.52%
3.4B
5.2B
-8.25% -21.56%
7.71
0.65
31.60% 35.63%
3.2B
704.5M
4.54% 11.22%
47.88
4.61
13.56% 10.15%
2.6B
6.4B
-2.27% -16.61%
13.15
0.4
-0.52% 17.01%
SMALL-CAP
1.7B
951.1M
-1.69% 17.81%
36.04
1.74
10.02% 1.99%
1.6B
-
0.59% 17.88%
18.77
3.24
- -
1.3B
1.4B
14.63% 3.78%
123.09
0.92
8.74% -56.93%
561.7M
2.8B
-12.95% -59.69%
-2.36
0.2
2.43% -140.13%

Financials for Humana

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue1.5%92,87091,48589,38386,36683,064
  S&GA Expenses1.2%12,67112,51512,05711,00010,121
EBITDA0.6%4,7184,6904,9894,590-
EBITDA Margin-0.9%0.05*0.05*0.06*0.05*-
Earnings Before Taxes-0.3%3,5683,5793,9183,5343,354
EBT Margin-1.8%0.04*0.04*0.05*0.04*-
Interest Expenses4.4%401384370348326
Net Income0.0%2,8062,8073,1433,0352,933
Net Income Margin-1.5%0.03*0.03*0.04*0.04*-
Free Cahsflow-58.7%3,4678,3852,7292,080-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-15.2%43,05550,76546,82046,30844,358
  Current Assets-22.3%26,18333,71127,21726,84024,893
    Cash Equivalents-62.7%5,06113,5585,1534,8643,394
  Net PPE0.1%3,2213,2183,1213,1893,073
  Goodwill0.5%9,1429,0968,91111,13911,092
Liabilities-19.6%27,68534,44831,31030,96628,255
  Current Liabilities-31.4%17,17825,05117,83917,53215,331
    LT Debt, Non Current15.9%9,0347,79811,29011,28510,541
Shareholder's Equity-6.2%15,31116,31715,51015,34216,080
  Retained Earnings-0.4%25,49225,60624,51123,91523,086
  Additional Paid-In Capital0.4%3,2463,2343,1533,1033,082
Accumulated Depreciation-2,874----
Shares Outstanding0.0%127127126--
Minority Interest-6.3%59.0063.0020.0023.0023.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-52.3%4,5879,6184,0003,4012,262
  Share Based Compensation-2.3%216221189184180
Cashflow From Investing-947.9%-1,006-96.00-6,023-5,716-6,556
Cashflow From Financing-614.2%-1,914-2683,8653,3023,015
  Dividend Payments2.6%392382372362354
  Buy Backs95.0%2,0961,0751,0741,07379.00

Risks for HUM

What is the probability of a big loss on HUM?

58.5%


Probability that Humana stock will be more than 20% underwater in next one year

19.2%


Probability that Humana stock will be more than 30% underwater in next one year.

0%


Probability that Humana stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HUM drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Humana was unfortunately bought at previous high price.

Drawdowns

Returns for HUM

Cumulative Returns on HUM

22.4%


10-Year Cumulative Returns

15.5%


7-Year Cumulative Returns

13.2%


5-Year Cumulative Returns

18.5%


3-Year Cumulative Returns

What are the long-term rolling returns for HUM?

FIve years rolling returns for Humana.

Annualized Returns

Which funds bought or sold HUM recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-28
Acrisure Capital Management, LLC
new
-
585,433
585,433
0.65%
2023-03-24
Longbow Finance SA
new
-
15,333,900
15,333,900
2.06%
2023-03-23
MetLife Investment Management, LLC
reduced
-1.83
658,244
18,754,900
0.15%
2023-03-17
American Portfolios Advisors
reduced
-7.59
-18,687
425,047
0.02%
2023-03-15
B. Riley Wealth Advisors, Inc.
added
8.63
99,705
774,705
0.02%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-7.18
-1,818,050
88,317,900
0.10%
2023-03-10
BAILLIE GIFFORD & CO
unchanged
-
1,170
28,170
-%
2023-03-08
Capital Asset Advisory Services LLC
added
3.15
23,316
223,316
0.02%
2023-03-06
NORTH STAR ASSET MANAGEMENT INC
reduced
-0.24
53,794
1,062,790
0.07%
2023-03-06
Rockefeller Capital Management L.P.
added
4.14
274,000
3,028,000
0.01%

1–10 of 45

Latest Funds Activity

Are funds buying HUM calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own HUM
No. of Funds

Humana News

Benzinga

Thinking about buying stock in Humana, Spotify, Mastercard, Altria ....

Benzinga,
12 hours ago

Marketscreener.com

Marketscreener.com

Nasdaq

Investopedia

StockNews.com

Schedule 13G FIlings of Humana

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
6.0%
7,623,150
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
8.97%
11,357,974
SC 13G/A
Feb 06, 2023
wellington management group llp
6.01%
7,611,181
SC 13G
Jan 25, 2023
blackrock inc.
9.2%
11,628,073
SC 13G/A
Jun 09, 2022
blackrock inc.
10.1%
12,733,508
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
8.1%
10,508,002
SC 13G/A
Feb 10, 2022
vanguard group inc
7.79%
10,008,322
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 01, 2022
blackrock inc.
8.8%
11,254,355
SC 13G/A

HUM Fair Value

Humana fair value in different scenarios

The table shows the Fair Value estimates for Humana for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

287.83

-41.06%

417.26

-14.56%

616.10

26.16%

806.15

65.07%

935.13

91.48%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Humana Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Humana

View All Filings
Date Filed Form Type Document
Mar 27, 2023
3
Insider Trading
Mar 23, 2023
4
Insider Trading
Mar 13, 2023
8-K
Current Report
Mar 08, 2023
ARS
ARS
Mar 08, 2023
DEF 14A
DEF 14A
Mar 08, 2023
DEFA14A
DEFA14A
Mar 03, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 01, 2023
424B5
Prospectus Filed
Mar 01, 2023
8-K
Current Report

Latest Insider Trading transactions for HUM

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-01
Feinberg David T
acquired
-
-
441
-
2023-02-28
JONES DAVID A JR/KY
gifted
-
-
-10,000
-
2023-02-27
Ventura Joseph C
gifted
-
-
-69.00
chief legal officer
2023-02-27
BROUSSARD BRUCE D
sold
-8,890,230
505
-17,575
president & ceo
2023-02-27
Huval Timothy S.
sold
-1,341,080
510
-2,628
chief administrative officer
2023-02-27
Ventura Joseph C
sold
-1,040,330
507
-2,048
chief legal officer
2023-02-24
BROUSSARD BRUCE D
acquired
-
-
28,494
president & ceo
2023-02-24
Huval Timothy S.
acquired
-
-
4,306
chief administrative officer
2023-02-24
BROUSSARD BRUCE D
sold (taxes)
-5,571,340
510
-10,919
president & ceo
2023-02-24
Fleming William Kevin
sold (taxes)
-919,457
510
-1,802
seg pres, pharmacy sol & ccao

1–10 of 50

Bruce D. Broussard
65535
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
ServicesHealth Care [Member]Health Care [Member]Health Care [Member]
Revenues:   
Premiums$ 87,712$ 79,822$ 74,186
Services4,7763,0551,815
Investment income3821871,154
Total revenues92,87083,06477,155
Operating expenses:   
Benefits75,69069,19961,628
Operating costs12,67110,12110,052
Depreciation and amortization709596489
Total operating expenses89,07079,91672,169
Income from operations3,8003,1484,986
Gain on sale of KAH Hospice(237)00
Interest expense401326283
Other expense (income), net68(532)103
Income before income taxes and equity in net (losses) earnings3,5683,3544,600
Provision for income taxes7624851,307
Equity in net (losses) earnings(4)6574
Net income2,8022,9343,367
Net loss (income) attributable to noncontrolling interests4(1)0
Net income attributable to Humana$ 2,806$ 2,933$ 3,367
Basic earnings per common share (in dollars per share)$ 22.20$ 22.79$ 25.47
Diluted earnings per common share (in dollars per share)$ 22.08$ 22.67$ 25.31

HUM Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 5,061$ 3,394
Investment securities13,88113,192
Receivables, net of allowances of $70 in 2022 and $83 in 20211,6741,814
Other current assets5,5676,493
Total current assets26,18324,893
Property and equipment, net3,2213,073
Long-term investment securities380780
Goodwill9,14211,092
Equity method investments749141
Other long-term assets3,3804,379
Total assets43,05544,358
Current liabilities:  
Benefits payable9,2648,289
Trade accounts payable and accrued expenses5,2384,509
Book overdraft298326
Unearned revenues286254
Short-term debt2,0921,953
Total current liabilities17,17815,331
Long-term debt9,03410,541
Other long-term liabilities1,4732,383
Total liabilities27,68528,255
Commitments and contingencies (Note 17)
Stockholders' Equity:  
Preferred stock, $1 par; 10,000,000 shares authorized; none issued00
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 20213333
Capital in excess of par value3,2463,082
Retained earnings25,49223,086
Accumulated other comprehensive (loss) income(1,304)42
Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021(12,156)(10,163)
Total stockholders' equity15,31116,080
Noncontrolling interests5923
Total equity15,37016,103
Total liabilities and equity$ 43,055$ 44,358